Announcements Trials

Browse Landscape

Phase

Phase NA 32 Phase EARLY_PHASE1 4 Phase 2 4 Phase 3 2 Phase 2/3 2 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 300 OTHER 293 NIH 58 NETWORK 4 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 6 Lymphoma, B-Cell 5 Uveal Melanoma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Recurrence 3 Polycystic Ovary Syndrome 3 Neoplasms, Plasma Cell 3 Multiple Myeloma 3 Hematologic Neoplasms 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER_GOV × Prostatic Neoplasms × Clear all

NCT05917860 2025-02-17

NeoADT-TULSA

Turku University Hospital

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡